Michael I. Middleton v. Regeneron Pharmaceuticals, Inc.

District Court, S.D. New York·Decided July 13, 2026·No. 7:25-cv-01984·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK MICHAEL I. MIDDLETON,

Plaintiff, OPINION AND ORDER -against-

REGENERON PHARMACEUTICALS, INC., 25-CV-01984 (PMH) Defendant.

PHILIP M. HALPERN, United States District Judge: Michael I. Middleton (“Plaintiff”), proceeding pro se, commenced this action on March 6, 2025, alleging discrimination and retaliation under the Age Discrimination in Employment Act (“ADEA”), 29 U.S.C. §§ 621 et seq, the New York City Administrative Code (“NYCHRL”), and the New York State Human Rights Law (“NYSHRL”) against Regeneron Pharmaceuticals, Inc. (“Defendant”).1 (Doc. 1, “Compl.”). 0F Pending before the Court is Defendant’s motion to dismiss under Federal Rule of Civil Procedure 12(b)(6). (Doc. 17; Doc. 18). Plaintiff opposed Defendant’s motion (Doc. 20, “Pl. Br.”), and the motion was fully briefed with the filing of the reply (Doc. 21). For the reasons set forth below, Defendant’s motion to dismiss is GRANTED. BACKGROUND The Court recites the facts herein only to the extent necessary to adjudicate the extant motion and draws them from the Complaint. The Court draws all reasonable inferences in Plaintiff’s favor. See Lesser v. TD Bank, N.A., 463 F. Supp. 3d 438, 445 (S.D.N.Y. 2020).

1 Although Plaintiff annexes a “[l]ist of defendants” to the Complaint, he served a copy of the summons and complaint on Defendant only, and has not made any effort to serve any of the individuals listed on that attachment as additional defendants. (Doc. 1-1). Because Plaintiff is given leave to replead, to the extent he intends to include any of those individuals as defendants in this action, he must specifically name such individuals as defendants in the amended complaint, obtain summonses as to those defendants, and properly serve them with the summonses and operative pleading. Plaintiff, who is 73 years old, began working for Defendant as the Director of Project Management in 2014. (Compl. at 3).2 Plaintiff observed, in August 2021, that he was being 1F excluded from participating in candidate interviews for potential hires. (Id.). He was also informed that his team was being relocated to a different building. (Id.). At the end of 2021, he received a positive performance evaluation, resulting in a merit increase and a bonus. (Id.). Plaintiff, in February 2022, was advised that he was “underperforming” and “earned too much.” (Id. at 3-4). Plaintiff was advised, in March 2022, that he should look for other job roles and in April, following that advice, Plaintiff submitted his CV for Defendant’s internal vacancy listings. (Id. at 4). That month he interviewed for two roles, one in Tarrytown and one in London. (Id.). Plaintiff was not hired for either role and in May 2022, he was terminated. (Id. at 5). Defendant provided Plaintiff with a Severance Agreement that included a compensation package contingent upon the release of any claims, to be signed and returned within 21 days. (Id. at 5). Plaintiff submitted the Severance Agreement on May 25, 2022 with additional handwritten amendments. (Id.). Defendant rejected the handwritten amendments. (Id.). Plaintiff appeared to

hand-deliver the signed Severance Agreement and was thereupon escorted off the premises. (Id.). On June 11, 2022, Plaintiff received an email from Sally Paull, Executive Vice President of Human Resources, informing Plaintiff that no changes would be made to the Severance Agreement, such that it was non-negotiable. (Id. at 5-6). She further stated she was “comfortable with the decision to eliminate [Plaintiff’s] role.” (Id. at 6). On July 25th and July 27th, Plaintiff sent confidential letters separately to Defendant’s Executive Counsel and Head of Compliance, addressing his concerns regarding Defendant’s treatment of him, including being escorted from the building. (Id.). Those letters were then forwarded to the individuals about whom Plaintiff was

2 Plaintiff does not comply with the pleading rule that directs a party to “state its claims . . . in numbered paragraphs, each limited as far as practicable to a single set of circumstances.” Fed. R. Civ. P. 10(b) (emphasis added). Citations to the parties’ filings correspond to the pagination generated by ECF. complaining. (Id.). Plaintiff then hired a lawyer for his discrimination claims. (Id.). Plaintiff alleges that Human Resources retaliated against him by withholding COBRA benefits until he signed a confidentiality agreement. (Id.). Plaintiff contends that he “engaged in protected activity by hiring the undersigned firm in connection with his age discrimination claim” and that Defendant retaliated against him by denying him COBRA benefits. (Id. at 7). On November 2,

2022, an AETNA/Regeneron Administrator confirmed that Plaintiff had timely registered for COBRA coverage, contrary to Defendant’s claim that Plaintiff had not elected COBRA coverage correctly. (Id. at 6). This litigation followed. STANDARD OF REVIEW On a Rule 12(b)(6) motion, a court may dismiss a complaint for “failure to state a claim upon which relief can be granted.” Fed. R. Civ. P. 12(b)(6). “To survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007)).3 A claim is plausible on its face “when the ple[d] factual 2F content allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Id. (citing Twombly, 550 U.S. at 556). “The plausibility standard is not akin to a ‘probability requirement,’ but it asks for more than a sheer possibility that a defendant acted unlawfully.” Id. The factual allegations pled “must be enough to raise a right to relief above the speculative level.” Twombly, 550 U.S. at 555. “When there are well-ple[d] factual allegations, a court should assume their veracity and then determine whether they plausibly give rise to an entitlement to relief.” Iqbal, 556 U.S. at

3 Unless otherwise indicated, case quotations omit all internal citations, quotation marks, footnotes, and alterations. 679. Thus, the Court must “consider the legal sufficiency of the complaint, taking its factual allegations to be true and drawing all reasonable inferences in the plaintiff’s favor.” Harris v. Mills, 572 F.3d 66, 71 (2d Cir. 2009). The presumption of truth, however, “is inapplicable to legal conclusions, and threadbare recitals of the elements of a cause of action, supported by mere conclusory statements, do not suffice.” Id. at 72. A plaintiff must provide “more than labels and

Free access — add to your briefcase to read the full text and ask questions with AI

Michael I. Middleton v. Regeneron Pharmaceuticals, Inc., (S.D.N.Y. 2026).

Michael I. Middleton v. Regeneron Pharmaceuticals, Inc. (Michael I. Middleton v. Regeneron Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Chavis v. Chappius
618 F.3d 162 (Second Circuit, 2010)
Burgos v. Hopkins
14 F.3d 787 (Second Circuit, 1994)
Mcpherson v. Coombe
174 F.3d 276 (Second Circuit, 1999)
Harris v. Mills
572 F.3d 66 (Second Circuit, 2009)
Smith v. Department of Justice
218 F. Supp. 2d 357 (W.D. New York, 2002)
Hoffman v. Parade Publications
933 N.E.2d 744 (New York Court of Appeals, 2010)
Vangas v. Montefiore Medical Center
823 F.3d 174 (Second Circuit, 2016)
Cuoco v. Moritsugu
222 F.3d 99 (Second Circuit, 2000)
Marcus v. Leviton Manufacturing Co.
661 F. App'x 29 (Second Circuit, 2016)